Skip to content
2000
Volume 5, Issue 8
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

NMR-based screening has become a powerful method for the identification and analysis of lowmolecular weight organic compounds that bind to protein targets and can be utilized in drug discovery programs. In particular, heteronuclear NMR-based screening can yield information about both the affinity and binding location of potential lead compounds. In addition, heteronuclear NMR-based screening has wide applications in complementing and facilitating conventional high-throughout screening programs. This article will describe several strategies for the integration of NMR-based screening and high-throughput screening. The marriage of these two techniques promises to be of tremendous benefit in the triage of hits that come from HTS, and can aid the medicinal chemist in the identification of quality leads that have high potential for further optimization.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/1386207023329996
2002-12-01
2025-07-10
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/1386207023329996
Loading

  • Article Type:
    Review Article
Keyword(s): high throughput; hts; nmr-based; nuclear magnetic resonance-based
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test